Tidal Trust III VistaShares Animal Spirits Daily 2X Strategy ETF

Tidal Trust III VistaShares Animal Spirits Daily 2X Strategy ETF

Fund · US45259A4316 · WILD (XNYS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Tidal Trust III VistaShares Animal Spirits Daily 2X Strategy ETF
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 94.270,00
Company Profile for Tidal Trust III VistaShares Animal Spirits Daily 2X Strategy ETF Fund
The VistaShares Animal Spirits Daily 2x Strategy ETF (WILD) is an actively managed exchange-traded fund that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the performance of an actively managed group of “animal spirits” securities for a single day. The fund aims to capitalize on behavioral and psychological factors driving investor sentiment and market trends by targeting companies that attract significant investor interest and market activity.

Company Data

Name Tidal Trust III VistaShares Animal Spirits Daily 2X Strategy ETF
Company VistaShares Animal Spirits Daily 2X Strategy ETF
Symbol WILD
Primary Exchange XNYS NYSE
ISIN US45259A4316
Asset Class Fund
Sector Financial Services
Industry Investment - Banking & Investment Services
Country United States of America
Currency USD
Employees -
IPO Date 2013-10-16

Stock Splits

Date Split
29.05.2012 13:1

Ticker Symbols

Name Symbol
NYSE WILD
More Shares
Investors who hold Tidal Trust III VistaShares Animal Spirits Daily 2X Strategy ETF also have the following shares in their portfolio:
GR.C.P.FIN. 26/UND. FLR
GR.C.P.FIN. 26/UND. FLR Bond
VERRICA PHARM.   NEW O.N.
VERRICA PHARM. NEW O.N. Share